Evidence map›Paper›PMID 34257391›Full record

ArticleJournal of human genetics2022

Cancer predisposition genes in Japanese children with rhabdomyosarcoma.

Hiroko Fukushima, Ryoko Suzuki, Yuni Yamaki, Sho Hosaka, Masako Inaba, Wataru Morii, Emiko Noguchi, Hidetoshi Takada

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hiroko FukushimaDepartment of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan. fkhiroko@md.tsukuba.ac.jp.
Ryoko SuzukiDepartment of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan.
Yuni YamakiDepartment of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan.
Sho HosakaDepartment of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan.
Masako InabaDepartment of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan.
Wataru MoriiDepartment of Medical Genetics, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Emiko NoguchiDepartment of Medical Genetics, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Hidetoshi TakadaDepartment of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan.
University of Tsukuba · JPUniversity of Tsukuba Hospital · JP

Funding

Japan Society for the Promotion of Science London (JSPS London) 17K16239
6 · The paper itself

Abstract

Rhabdomyosarcoma (RMS) is one of the most common soft tissue sarcomas in children. Germline mutations in cancer-predisposition genes have been detected in approximately 10% of pediatric cancers. However, the genetic background of RMS is still unclear, especially in Asian children. DNA was extracted from the peripheral blood of children with RMS and cancer-associated genes analyzed using targeted re-sequencing. Twenty patients participated in this study. There were three deaths due to RMS. One patient developed a second neoplasm. Nine patients had long-term co-morbidities. Six pathogenic variants were found in five patients: one nonsense variant of DICER1, one exon deletion of TP53, and three missense variants of BUB1B, LIG4, and MEN1. Two of the five patients had a family history of cancer. Two patients with missense variants of LIG4 had long-term co-morbidities of drug-induced cardiomyopathy. The missense variants of LIG4, essential for DNA double-strand break repair, were detected in two unrelated patients. While this is the first report of the germline genetic analysis of Japanese children with RMS with detailed clinical information, the frequency of the variant was almost equivalent to that of previous reports from western countries. Unbiased exon sequencing may be useful to clarify the pathogenesis of RMS in children and in predicting the clinical course of these patients.

Indexed as

Biomarkers, TumorGenetic Association StudiesGenetic Predisposition to DiseaseOncogenesAge FactorsChildGenetic TestingHumansJapanRhabdomyosarcomaBiomarkers, Tumor

Identifiers

PMID34257391
OpenAlexW3139227489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.